OBJECTIVES: Human papillomavirus (HPV) is considered a necessary cause of cervical cancer. The aim of the current study was to determine the burden of HPV infection among randomly sampled Danish women before the vaccine against HPV is implemented. Further we assessed the risk factor profile for prevalent high risk (HR) HPV infection and infection with multiple HR HPV types. METHODS: In the present cross-sectional study, we used baseline data from a population-based cohort study where participants were interviewed and had a gynecological examination. Cervical samples were analyzed for HR HPV using Hybrid capture 2 in 10,544 women aged 20-29 years and 1443 women aged 40-50 years. Genotyping was performed using LiPA. RESULTS: The prevalence of HR HPV was 17.9% and 4.4% in women aged 20-29 years and 40-50 years, respectively. HPV16 was the most common HR type overall and among women with abnormal cytology. Multiple HPV types were highly prevalent, notably in the younger cohort. Lifetime number of sexual partners was the main risk factor for HR HPV infection (adj. OR = 2.8 and OR = 3.4 for > or =15 partners vs. < or =4 in respectively younger and older women), whereas number of recent sexual partners was only associated with risk in younger women. Number of partners, oral contraceptive use and self-reported chlamydia infection increased the risk of having multiple HR HPV types (compared to having a single HR HPV type). CONCLUSIONS: HR HPV infection was common among younger women, with HPV16 as the predominant type. We confirmed the importance of sexual activity for the risk of HR HPV infection. In addition, we found that sexual behavior also play an important role for the risk of having multiple HR HPV types.
OBJECTIVES:Human papillomavirus (HPV) is considered a necessary cause of cervical cancer. The aim of the current study was to determine the burden of HPV infection among randomly sampled Danish women before the vaccine against HPV is implemented. Further we assessed the risk factor profile for prevalent high risk (HR) HPV infection and infection with multiple HR HPV types. METHODS: In the present cross-sectional study, we used baseline data from a population-based cohort study where participants were interviewed and had a gynecological examination. Cervical samples were analyzed for HR HPV using Hybrid capture 2 in 10,544 women aged 20-29 years and 1443 women aged 40-50 years. Genotyping was performed using LiPA. RESULTS: The prevalence of HR HPV was 17.9% and 4.4% in women aged 20-29 years and 40-50 years, respectively. HPV16 was the most common HR type overall and among women with abnormal cytology. Multiple HPV types were highly prevalent, notably in the younger cohort. Lifetime number of sexual partners was the main risk factor for HR HPV infection (adj. OR = 2.8 and OR = 3.4 for > or =15 partners vs. < or =4 in respectively younger and older women), whereas number of recent sexual partners was only associated with risk in younger women. Number of partners, oral contraceptive use and self-reported chlamydia infection increased the risk of having multiple HR HPV types (compared to having a single HR HPV type). CONCLUSIONS:HR HPV infection was common among younger women, with HPV16 as the predominant type. We confirmed the importance of sexual activity for the risk of HR HPV infection. In addition, we found that sexual behavior also play an important role for the risk of having multiple HR HPV types.
Authors: William Copeland; Lilly Shanahan; Shari Miller; E Jane Costello; Adrian Angold; Barbara Maughan Journal: Am J Psychiatry Date: 2010-05-17 Impact factor: 18.112
Authors: Anne F Rositch; Charles Poole; Michael G Hudgens; Kawango Agot; Edith Nyagaya; Stephen Moses; Peter J F Snijders; Chris J L M Meijer; Robert C Bailey; Jennifer S Smith Journal: J Infect Dis Date: 2011-11-04 Impact factor: 5.226
Authors: Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Shu-Kuang Lee; Sandra F O'Reilly; Nancy B Kiviat; Laura A Koutsky Journal: Sex Transm Dis Date: 2012-11 Impact factor: 2.830
Authors: Carrie M Nielson; Robin B Harris; Roberto Flores; Martha Abrahamsen; Mary R Papenfuss; Eileen F Dunne; Lauri E Markowitz; Anna R Giuliano Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-03-24 Impact factor: 4.254
Authors: Joseph E Tota; Agnihotram V Ramanakumar; Mengzhu Jiang; Joakim Dillner; Stephen D Walter; Jay S Kaufman; François Coutlée; Luisa L Villa; Eduardo L Franco Journal: Am J Epidemiol Date: 2013-05-09 Impact factor: 4.897
Authors: Bárbara Simas Chagas; Manola Comar; Ana Pavla Almeida Diniz Gurgel; Sérgio Paiva; Silva Seraceni; Antonio Carlos de Freitas; Sergio Crovella Journal: PLoS One Date: 2015-07-15 Impact factor: 3.240
Authors: Henrike J Vriend; Johannes A Bogaards; Fiona R M van der Klis; Mirte Scherpenisse; Hein J Boot; Audrey J King; Marianne A B van der Sande Journal: PLoS One Date: 2013-04-23 Impact factor: 3.240
Authors: Rosane Ribeiro Figueiredo Alves; Marília Dalva Turchi; Lyana Elias Santos; Eleuse Machado de Britto Guimarães; Mônica Maria Danda Garcia; Mirian Socorro Cardoso Seixas; Luisa Lina Villa; Maria Cecília Costa; Marise Amaral Rebouças Moreira; Maria de Fátima da Costa Alves Journal: BMC Public Health Date: 2013-11-04 Impact factor: 3.295